|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���ٻ���ڵ��������� |
|
Ƥ������ |
|
���������� |
|
������Ӧ |
| ��������������� | |
|
�ܽ��� |
|
֣�� |
| PubMed | |
|
Article by |
|
Article by |
TARC��ijЩƤ���������о���չ
�ܽ���, ֣��
�㽭��ѧ�����ڶ�ҽԺƤ���� ���� 310009
����������һ����յ��ġ������͵�ǰ��֢ϸ������,����֢ϸ�������������á����ݽṹ�ص��������ӷ�Ϊ4������:C-C���塢C-X-C���塢C���塢C-X-X-X-C���塣C-C������Ҫ�����������ϸ����ijЩTϸ����Ⱥ�����ٻ���ڵ�����������C-C�����е�һԱ,ͨ����������������CCR4���,ѡ��������Th2ϸ��,������֢��
[2] Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Iht Immunol, 1999, 11:81-88.
[3] Hijnen D, De Bruin-Weller M, Oosting B, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases:TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol, 2004, 113:334-340.
[4] Fujisawa T, Fujisawa R, Kato Y, et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol, 2002, 110:139-146.
[5] Zheng X, Nakamura K, Furukawa H, et al. Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis. J Dermatol, 2003, 30:26-32.
[6] Tsuda T, Tohyama M, Yamasaki K, et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci, 2003, 31:37-42.
[7] Zheng X, Nakamura K, Tojo M, et al. Ultraviolet A irradiation inhibits thymus and activation-regulated chemokine (TARC/CCL17) production by a human keratinocyte HaCaT cell line. Eur J Dermatol,2003, 13:348-353.
[8] Xiao T, Fujita H, Saeki H, et al. Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma. Cytokine, 2003, 23:126-132.
[9] Lin L, Nonoyama S, Oshiba A,et al. TARC and MDC are produced by CD40 activated human B cells and are elevated in the sera of infantile atopic dermatitis patients. J Med Dent Sci, 2003, 50:27-33.
[10] Kakinuma T, Wakugawa M, Nakamura K, et al. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol, 2003, 148:203-210.
[11] Kakinuma T, Sugaya M, Nakamura K, et al. Thymus and activationregulated chemokine (TARC/CCL17) in mycosis fungoides:serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol, 2003, 48:23-30.
[12] Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood, 2002, 99:1505-1511.
[13] Ohshima K, Tutiya T, Yamaguchi T, et al. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Stemberg (H&RS) cells in Hodgkin disease:Relation with expression of CXC and CC chemokines on H&RS cells. Int J Cancer, 2002, 98:567-572.
[14] Akpek EK, Jabs DA, Gerard HC, et al. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci,2004, 45:185-190.
[15] Okamoto H, Koizumi K, Yamanaka H, et al. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus. J Rheumatol, 2003, 30:2369-2373.
[16] Hase K, Tani K, Shimizu T,et al. Increased CCR4 expression in active systemic lupus erythematosus. J Leukoc Biol, 2001,70:749-755.
[17] Yamada M, Yagita H, Inoue H, et al. Selective accumulation of CCR4 + T lymphocytes into renal tissue of patients with lupus nephritis. Arthritis Rheum, 2002, 46:735-740.
[18] Ogawa H, Nishimura N, Nishioka Y, et al. Adenoviral interleukin12 gene transduction into human bronchial epithelial cells:up-regulation of pro-inflammatory cytokines and its prevention by corticosteroids. Clin Exp Allergy, 2003, 33:921-929.
[19] Sekiya T, Yamada H, Yamaguchi M,et al. Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy, 2002,57:173-177.
[20] Leung TF, Wong CK, Chan IH, et al. Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol, 2002, 110:404-409.
[21] Yao K, Iguchi Y, Sato K, et al. An immunohistological study of the localization characteristics of thymus and activation-regulated chemokine in the allergic inferior turbinate mucosa with reference to the effectiveness of trichloroacetic acid treatment. Am J Rhinol, 2001, 15:395-402.